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pilepsy is one of the most common neurologi-
cal disorders (~8 000 000 patients in the European
Union).It has devastating behavioral,social,and occu-
pational consequences,and is associated with accumu-
lating brain damage and neurological deficits.Epilepsy
comprises a large number of syndromes, which vary
greatly with respect to their clinical features,treatment,
and prognosis.However,all of these syndromes share the
characteristic clinical hallmark of epilepsy—recurrent
spontaneous seizures.
Even though the key manifestation of all epilepsies is
recurrent seizures,the etiologies that can give rise to an
increased propensity of the human brain to generate syn-
chronized neuronal activity and seizures are diverse.
Epileptic seizures are associated with overt causes,such as
certain central nervous system (CNS) tumors or neurode-
velopmental abnormalities,CNS trauma,or inflammation
(symptomatic epilepsies).In a small number of epilepsy
patients, a mutation in a single gene suffices to cause
chronic seizures.Additionally,a large group of epilepsies
has a yet-unknown etiology (idiopathic epilepsies).Studies
of the genetic or molecular and cellular causes of epilepsy
have to take account of the fact that epilepsy is not a uni-
form disorder,but a mixture of many different entities.A
precise analysis of the clinical, neurophysiological, and
neuropathological phenotype of human epilepsies with a
definition of homogenous subgroups/syndromes is a pre-
requisite not only for genetic studies,but also for the devel-
opment of appropriate animal models to study the cellu-
lar basis of seizures and epilepsy.Because of the etiological
diversity of epilepsy, modern approaches to epilepsy
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As one of the most common neurological disorders,
epilepsy has devastating behavioral, social, and occupa-
tional consequences and is associated with accumulating
brain damage and neurological deficits. Epilepsy com-
prises a large number of syndromes, which vary greatly
with respect to their etiology and clinical features, but
share the characteristic clinical hallmark of epilepsy—
recurrent spontaneous seizures. Research aimed at
understanding the genetic, molecular, and cellular basis
of epilepsy has to integrate various research approaches
and techniques ranging from clinical expertise, func-
tional analyses of the system and cellular levels, both in
human subjects and rodent models of epilepsy, to
human and mouse genetics. This knowledge may then
be developed into novel treatment options with better
control of seizures and/or fewer side effects. In addition,
the study of epilepsy has frequently shed light on basic
mechanisms underlying the function and dysfunction of
the human brain. 
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(e-mail: christian.elger@ukb.uni-bonn.de)research involve many different fields.These include clin-
ical fields such as clinical epileptology and neurosurgery,
neurology,psychiatry,and neuropathology,but also basic
research areas such as human genetics,neuropsychology,
immunology, neurophysiology, neurophysics, molecular
biology and transgenics,developmental neurobiology,and
neuropharmacology.
The ultimate goal of studies into the molecular and cel-
lular mechanisms of epilepsy is to develop novel, and
more effective,therapies.This may be approached in sev-
eral ways.Firstly,a better understanding of the underly-
ing disease mechanisms may in some instances lead to
the identification of novel treatment options.Secondly,it
is important to understand why currently available ther-
apies do not help certain patients, while they are very
effective in others. Finally, another goal of epilepsy
research is to identify mechanisms underlying side effects
of drug therapy,because these often limit drug therapy.
In addition to the intrinsic value of studying disease
processes in one of the most common neurological disor-
ders, epilepsy research is an excellent model for under-
standing basic mechanisms of CNS function and plasticity,
in particular in the human brain,for several reasons.Firstly,
seizures are known to initiate a large number of plastic
changes on a molecular and cellular level in the brain.
Many of these plasticity mechanisms have been recognized
as key components of normal brain function (ie, brain
development or learning and memory) or in other neuro-
logical disorders.Secondly,understanding the cellular basis
of aberrant synchronized discharges of neurons during
epileptic seizures also yields insights into the mechanisms
of normal synchronization in the brain.Finally,the neces-
sity to perform invasive electrode (depth and subdural)
recordings in patients with epilepsy results in unique
opportunities to study human cognitive processes at
extremely high time resolution by recording field or even
single unit potentials during cognitive tasks.This technique
can be combined with different functional imaging tech-
niques,which ideally complement invasive recordings from
the human brain by providing excellent spatial resolution.
Research into the basic 
mechanisms of epilepsy
The study of idiopathic genetic epilepsies: how do 
single gene mutations cause epilepsy?
Genetic factors are the major determinants in at least
40% of all epilepsies;these are designated as “idiopathic
epilepsies.”Only about 2% of these idiopathic epilepsies
are inherited as monogenic disorders,in which one gene
conveys the major heritable impact,while environment
and lifestyle play a limited role. Genetic studies have
allowed identification of the first disease genes that
define monogenic idiopathic epilepsies.
1,2 In these cases,
genetic studies have identified causal gene variants,many
of them neuronal ion channels,receptors,or associated
proteins.Subsequently,the function of these variants was
examined carefully in expression systems, and specific
functional changes were found. These analyses, while
compelling in implicating specific genes in idiopathic
epilepsies,are not the last word in understanding how a
gene mutation leads to a behavioral and clinical pheno-
type.We are beginning to obtain such an understanding
in some instances from transgenic mouse models that
carry disease-associated gene variants.
3The advantage of
such models is that they harbor human disease-associ-
ated gene variants,and can be examined at various points
during the development of epilepsy with in vitro and
molecular techniques.The limitation of such models is
that the mechanisms of epileptogenesis may not be the
same in mice and humans, and that disease-associated
human gene variants are expressed on a background of
mouse genes that may interact in unexpected ways with
the human ortholog. Nevertheless, such studies are
increasingly part of an integrated strategy to understand
the mechanisms of monogenic epilepsies involving both
human genetics and physiological,and molecular studies
in transgenic mouse models.
The study of focal epilepsy
What are the mechanisms of seizures?
By far most types of epilepsies,however,are not mono-
genic. Rather, they most probably involve both the
effects of various combinations of gene variants, envi-
ronmental factors, and precipitating injuries early dur-
ing development.The relative importance of these fac-
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Selected abbreviations and acronyms
AED antiepileptic drug
AHS Ammon's horn sclerosis
CNS central nervous system
fMRI functional magnetic resonance imaging
SE   status epilepticus
TLE temporal lobe epilepsytors in common focal epilepsies such as temporal lobe
epilepsy (TLE) is unknown. For obvious reasons, it is
difficult to investigate how these epilepsies develop over
time prior to the first clinical manifestation.This is prob-
ably why research in the field has focused more on iden-
tifying key mechanisms that govern abnormal excitabil-
ity and synchronization in chronic epilepsy,in particular
those which might be potential targets for therapeutic
manipulation.Animal models generated for this goal
have been selected with the rationale that they should
reproduce the neuropathological, clinical, and physio-
logical features of the chronic stage of epilepsy.This has
been achieved to some extent for temporal lobe
epilepsy. Models of temporal lobe epilepsy (TLE)
include the kainate model,
4 the pilocarpine model,
5 and
the self-sustaining limbic status model.
6 All rely on the
induction of status epilepticus (SE) either pharmaco-
logically (with the ionotropic glutamate receptor agonist
kainate or the muscarinic agonist pilocarpine), or via
electrical stimulation (self-sustaining limbic status
model).After a period of a few weeks,animals that have
experienced SE exhibit several hallmarks of temporal
lobe epilepsy, including (i) spontaneous seizures; (ii) a
pattern of neuropathological damage similar to a subset
of temporal lobe epilepsy patients with segmental hip-
pocampal cell loss,gliosis and axonal reorganization;and
(iii) dispersion of granule cells. In TLE, we have the
unique possibility of validating such animal models
because tissue from TLE patients is available from
epilepsy surgery. From comparative neuropathological
studies, we know that the pattern of damage in the
abovementioned models is surprisingly close to that seen
in a subgroup of TLE patients with so-called Ammon’s
horn sclerosis (AHS). Patients with AHS also display
severe segmental neuron loss,axonal reorganization,and
gliosis, along with dispersion of granule neurons.
7-9 It
should be noted that in other instances, these epilepsy
models differ from the human condition. For instance,
damage in the pilocarpine model is not restricted to the
hippocampus, involving instead many other brain
regions. Nevertheless, these and similar models have
been used extensively to study cellular and molecular
changes in chronic epilepsy,and how these might lead to
seizure generation.These changes have in some cases
been compared with data obtained from human neurons
obtained from epilepsy surgical specimens.
10
A further group of TLE patients does not display the
neuropathological features of AHS, even though they
experience seizures originating from the mesial tempo-
ral lobe.
7-9 In this group of TLE patients,epilepsy is often
a consequence of a mesial temporal lobe tumor or devel-
opmental malformation.An animal model that is thought
to replicate some features of these human patients is the
kindling model. In this model, repeated application of
subthreshold electrical stimulation to limbic structures
results in the expression of permanent limbic hyperex-
citability. In this model, significant neuropathological
damage is largely absent.In comparison with studies on
human and experimental TLE, work on models of
epilepsies with neocortical seizure foci has been relatively
scarce,even though such models can also be validated in
human in vitro studies.
Models of TLE have proven useful as a complementary
strategy to investigations on human epileptic brain tissue.
In experiments on human tissue,a fundamental problem
is the lack of living control tissue.Very rarely,nonepilep-
tic human control tissue is available from the penumbra
of tumor resections in the temporal lobe.Other than this
rare commodity,experimenters are left with the option
of comparing epileptic tissue with autopsy control tissue,
which is impossible for physiological and some molecu-
lar biological approaches. A further, commonly used
approach is to compare tissue from patients with AHS vs
lesion-associated epilepsy.This strategy has allowed the
investigation of the expression of candidate molecules
associated with changes present only in one of these
patient groups. For instance, molecules important in
synaptic reorganization would be expected to be present
in specific areas in AHS, but not in lesion-associated
epilepsy. Studies in animal models, on the other hand,
always require validation with studies on human tissue
to demonstrate their relevance to the human disorder
unequivocally.
11 However,animal models do complement
human studies in important ways.Firstly,animal models
allow molecular and functional changes to be studied in
detail without the constraints imposed by the lack of con-
trol material in experiments with human tissue.Further,
having identified clear molecular changes,animal mod-
els allow us to determine the importance of such changes
for hyperexcitability and epileptogenesis.This question
is important because a large number of regulated can-
didate molecules have been identified,all of which may
be potentially important in the development of epilepsy.
A major challenge will be to determine which of these
manifold changes are functionally important in common
forms of epilepsy.To decipher the causal role of candi-
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9date genes,it has become increasingly accepted that it is
necessary to generate cell-specific and inducible gain- as
well as loss-of-function models on a more systematic
scale than previously attempted.Such approaches may
be realized using viral transfer of small interfering RNAs
(siRNAs),or transgenic models that allow cell-specific
and inducible genetic modifications.Finally,animal mod-
els allow to study some aspects of epileptogenesis,which
is virtually impossible in human tissue, because speci-
mens are only obtained late during the disease course.
What are the mechanisms of epileptogenesis?
Broadly speaking, epileptogenesis can be defined as a
plastic process leading from a normal to a chronically
epileptic brain. Precipitating brain insults (ie, febrile
seizures,local infections,SE,ischemia,or trauma) in con-
cert with genetic susceptibility factors are thought to trig-
ger such persistent changes. As explained above, to
directly address this issue in human subjects is extremely
difficult. In recent years, investigators have therefore
increasingly turned to animal models for this purpose.In
the case of TLE,most investigators have studied epilep-
togenesis after an initial SE.It is important to realize that
TLE models replicate the chronic features of TLE rea-
sonably well.It is however not clear how much the mech-
anisms underlying SE-induced epileptogenesis overlap
with the mechanisms underlying epileptogenesis in TLE
patients,in whom this process is likely multifactorial and
not triggered by SE.Nevertheless,studies of epileptoge-
nesis in SE models have been worthwhile because they
have resulted in an increased understanding of the basic
mechanisms underlying key features of AHS, such as
sprouting,cell death,and gliosis.
It may seem easier to establish models of epileptogene-
sis in symptomatic epilepsies,for instance epilepsy asso-
ciated with CNS tumors,developmental malformations,
or CNS trauma,for the simple reason that the initial pre-
cipitating injury is known, and can be replicated quite
well in many cases.However,developing such models has
proven surprisingly elusive.Models for tumor-associated
epilepsy are scarce,and have relied on the injection of
rapidly proliferating tumor cell lines into the brain of
rodents.
12While potentially valuable to assess the conse-
quences of a rapidly growing malignancy in the CNS,
these models are probably not that informative on mech-
anisms of epileptogenesis and seizure generation
involved in human epilepsy patients. This is mainly
because the tumors that are likely to cause epilepsy are
mostly low-grade tumors with slow proliferation.The rea-
sons for this association are unknown.It will be neces-
sary to create additional models aimed at replicating fea-
tures of these tumors. Regarding developmental
malformations, there are several models in which the
proper formation of cortical structures has been dis-
rupted.These include models in which drugs are applied
during cortical development that arrest neuronal migra-
tion,or in which lesions are applied to the cortex during
cortex formation,which also lead to formation of a cor-
tex with a disturbed laminar organization.
13 In trauma
models,fluid percussion injury results in a circumscribed
traumatic cortical injury zone.
14These models have been
informative because they have revealed manifold
changes in excitability in and surrounding the abnormal
cortical areas,and address the underlying mechanisms.
However,it is not yet clear if these models lead to symp-
tomatic epilepsy.More recently,genetic models of corti-
cal malformations have been introduced.These models
rely on the temporally selective and cell-type specific dis-
ruption of genes important in neuronal differentiation
and migration. A further intriguing model that may
address a common mechanism in many epilepsies is dis-
ruption of the blood-brain barrier.It has been recently
shown that focal disruption of the blood-brain barrier
results in development of a hyperexcitable focus.
15,16 Since
blood-brain barrier disruption is a common feature of
status epilepticus,ischemia,trauma,and CNS tumors,it
may be that this is a common mechanism for hyperex-
citability in these models.The proliferation of these and
other models has led to an intense discussion in the field
regarding the validity of such models for the human con-
dition.A worthwhile aspect of this discussion is that it has
led to an awareness that animal models only replicate
specific aspects of any human condition,and it is para-
mount to be aware of the areas where a specific model is
informative versus the ones where it is not.
What are the key questions that have been addressed in
studies of epileptogenesis? Firstly,experiments primar-
ily in post-status models of epileptogenesis have
addressed the role of changes in voltage- and transmit-
ter-operated ion channels in epileptogenesis.Generally,
activity-dependent changes in neuronal function can be
subdivided into changes in synaptic communication
between neurons (termed synaptic plasticity), and
changes in intrinsic membrane properties of neurons
(termed intrinsic plasticity) that govern how synaptic
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input is integrated. Work on synaptic plasticity has
focused on changes in the expression and function of
neurotransmitter receptors at synapses, as well as
changed properties of presynaptic neurotransmitter
release. Research on intrinsic plasticity has addressed
changes in voltage-gated ion channels in the somatic,
dendritic,and axonal membrane of neurons.
17There have
been multiple such changes described convincingly in the
literature.A crucial question is how to evaluate the role
of individual molecular changes seen in animal models
in the development of epilepsy.There are several strate-
gies that could be used to this end. Perhaps the most
straightforward of these is to specifically interfere genet-
ically or pharmacologically with ion channel regulation.
Due to the novel genetic tools available in recent years,
this is becoming more and more feasible. To transfer
these types of studies to the human is more difficult.As
stated above, human tissue obtained from epilepsy
patients reflects the end stage of chronic epilepsy in most
cases.It is therefore doubtful that human tissue can serve
as a useful control for animal models at an early stage of
epileptogenesis.One avenue which may provide a useful
link between animal models and human epilepsy,how-
ever,is the use of genetic techniques to address whether
polymorphisms in ion channel genes,associated proteins,
or relevant transcription factors are associated with an
increased propensity to develop epilepsy.
What causes changes in ion-channel function? The
underlying molecular mechanisms are just beginning to
be unraveled.One feature of epileptogenesis is the selec-
tive and coordinated regulation of transcription.This reg-
ulation affects mRNA levels encoding for groups of ion
channels.The mechanisms that drive altered transcrip-
tion have been identified in only few cases.Identification
of the responsible transcription factors is one possible
avenue to inhibit specific features of epileptogenesis.
Persistent changes in transcription,however,are not only
determined by a persistent activation of transcription fac-
tors,but can also be caused by changes in the chromatin
state or autoregulatory feedback loops involving key
transcription factors.Following transcription,alterations
at the post-transcriptional level may be caused by
changes in translational regulation.Finally,trafficking of
ion-channel subunit proteins,as well as post-translational
modifications, are important determinants of function
that may be altered in chronic epilepsy.Understanding
changes in intrinsic neuronal properties and synaptic
function are also relevant for understanding mechanisms
of drug actions,as well as why resistance to these drugs
occurs.A large number of voltage-gated ion channels and
some presynaptic proteins are targets for antiepileptic
drugs,and changes in these targets may cause reduced
drug sensitivity (explained in more detail below).
In addition to changes in membrane-bound ion channels,
epileptogenesis is associated with large changes in mito-
chondrial function,including mitochondrial DNA deple-
tion,failure of energy supply,and production of reactive
oxygen species.
18,19 Such changes play a large role in the
initiation of cell death cascades.Studies on mitochondr-
ial function have been conducted in chronic experimen-
tal and human epilepsy.As above,studies on the mecha-
nisms underlying the development of mitochondrial
dysfunction are difficult in human tissue obtained at
chronic stages. Here also, genetic studies provide an
important link to epileptogenesis.An increasing number
of studies have addressed whether genetic variability in
genes encoding mitochondrial proteins confers suscepti-
bility to epileptogenesis.
20
An intriguing novel facet of epileptogenesis, that will
likely necessitate the development of new model systems,
is the involvement of immune cells in the development
of epilepsy.Immune cells profoundly influence processes
in the normal brain, such as neurogenesis or synaptic
plasticity. The link between neuroimmunological
processes and epilepsy is highlighted by inflammatory/
autoinflammatory epileptic syndromes (eg,Rasmussen
encephalitis or limbic encephalitis).Innate immune cells
may not only play a role in the pathogenesis of these rel-
atively rare epileptic syndromes,but also in the process
of epileptogenesis in common chronic epilepsies which
were not previously considered to have “encephalitic”
components.
21-23
How does epilepsy research 
lead to improved therapies?
In many patients with epilepsy, seizures are well-con-
trolled with currently available antiepileptic drugs.
However,seizures persist in a considerable proportion of
these patients.
24The exact fraction of epilepsy patients
that are considered refractory varies in the literature,
mostly because the criteria for classification as pharma-
coresistant have varied.Nevertheless,a substantial frac-
tion (~30%) of epilepsy patients does not respond to any
of two to three first-line antiepileptic drugs (AEDs),
despite administration in an optimally monitored regi-men.
25 Despite the clinical relevance of this phenomenon,
the cellular basis of pharmacoresistance has remained
elusive.However,integrated strategies integrating clini-
cal,genetic,and molecular physiological techniques are
providing some insight into possible mechanisms.What
are the key strategies that can be used to unravel mech-
anisms of pharmacoresistance?
The first approach is pharmacogenomic.The ultimate
goal of pharmacogenomics is to define the contributions
of genetic differences in drug response.
26The variability
of an individual’s response to a given drug can be con-
siderable, and identifying causal genetic factors is
expected to lead to improved safety and efficacy of drug
therapy through use of genetically guided,individualized
treatment.Pharmacogenomic approaches require both
substantial clinical and genetic expertise.Following delin-
eation of pharmacoresistant and pharmacoresponsive
patient groups,powerful tools for disease gene mapping
and identification afforded by the human genome pro-
ject can be exploited.These tools,which include a large
number of catalogued sequence variants,permit genome-
wide studies for the identification of genetic loci under-
lying diseases and related phenotypes, including the
response to drug treatment. These studies may allow
identification of novel gene variations conferring risk for
the development of epilepsy and pharmacoresistance.
While this approach sounds straightforward,it is far from
simple in practice.This is also clear from the large num-
ber of polymorphisms found in such association studies
which could not be reproduced in replication studies.
Major problems that still have to be overcome are firstly,
that pharmacoresponse may not be determined by a sin-
gle gene polymorphisms,rather,it may be the result of
a combination of polymorphisms.Accordingly,the impact
of single genes may be rather small, requiring large
patient cohorts. In addition, gathering large patient
cohorts prospectively, which are carefully matched
according to their drug response, is extremely difficult
and requires collaboration between epilepsy centers.
Finally,it will be necessary to address experimentally in
those cases in which polymorphisms are found in associ-
ation studies whether they have biologically plausible
effects that may result in pharmacoresistance.It is clearly
worthwhile to exploit such strategies to the utmost,
because genetic approaches can nowadays provide a
genome-wide analysis at comparatively low cost.Thus,
we are not limited by our preconceptions regarding the
specific molecules important in pharmacoresistance.
An alternate approach to the problem of pharmacore-
sistance has been to examine directly the response of
drug targets in epileptic tissue.This work has focused on
targets such as voltage-gated sodium channels,for which
AED responsiveness is well established.
27 Subsequently,
the response of channels to AEDs was investigated in
both animal models of TLE and human epilepsy.
10 In
some cases,as for voltage-gated sodium channels,a loss
of sensitivity of the channel complex to AEDs was found,
both in experimental and human epilepsy.Importantly,
such in-vitro data can be correlated with the clinical phe-
notype.Indeed,in the case of carbamazepine,pharma-
coresistance observed clinically was found to correlate
with a loss of carbamazepine sensitivity of voltage-gated
sodium channels.This strategy may be integrated with
genetic approaches to provide a potentially very infor-
mative approach to pharmacoresistance.The increasing
availability of genetic information also on epilepsy
patients who undergo epilepsy surgery opens the possi-
bility to perform genetic analyses on key molecules
implicated in the response to AEDs (ie, ion channels,
presynaptic proteins,or drug transporters).Subsequent
to the epilepsy surgery,a number of experiments can be
done on human tissue from these patients. Firstly, ion
channel or drug transporter function can be assessed
directly. Secondly, seizure activity can be elicited in
human brain slices, and the pharmacoresponse of this
activity can be quantitatively determined.In both cases,
a correlation with genetic information can provide use-
ful information on the functional relevance of genetic
variability.
The analyses in human tissue—while potentially very
useful—are hampered by the fact that human tissue is
only available from a subgroup of epilepsy patients.This
has sparked a quest for other suitable human model sys-
tems. One possibility is to use cells generated from
human embryonic stem cells and differentiated into
either neurons or glial cells in vitro.This approach would
permit to test the effects of antiepileptic drugs in a cell
model with a human background.Alternatively,it may
be possible to isolate adult human stem cells from
epilepsy surgical specimens,amplify them and generate
appropriate neural populations.The latter approach has
the advantage that the genetic phenotype of the patient
is available for individual interpretation of differential
drug responses. In addition to experiments aimed at
understanding mechanisms of drug resistance, and the
development of new drugs,other avenues for treatment
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of epilepsy have been explored.One of these avenues is
the transplantation of defined neuronal populations into
either the epileptic focus itself or into sites that con-
tribute to seizure generalization.It has been shown that
such approaches can ameliorate seizure activity.
28 An
alternate approach is to predict and prevent seizures with
invasive recording and stimulation techniques.
29 Seizure
prediction is a field of great interest in the clinical and
basic neuroscience communities.This is not only because
of its potential clinical application in warning and thera-
peutic antiepileptic devices, but also for its promise of
increasing our understanding of the mechanisms under-
lying epilepsy and seizure generation.
Mechanisms of cognitive deficits 
associated with epilepsy
Epilepsy is frequently associated with cognitive deficits
that may be due to an a-priori brain pathology, plastic
changes induced by the epilepsy,adverse effects of drug
treatment,or epilepsy surgery.The prevalence and clinical
importance of cognitive deficits has triggered intense
research activity in this field,in particular concerning pre-
and postsurgical memory and language impairments.
However,epilepsy and the employed invasive diagnostic
and therapeutic procedures also provide neuroscientists
with a unique and unprecedented opportunity to study the
neurophysiological basis of cognition and emotions in vivo.
The specific techniques that can be used for such clinical
and cognitive analyses are,for instance,recordings from
implanted depth electrodes,which provide a high tempo-
ral resolution of activity in the cortex or deeper brain
structures,in particular the hippocampus.
30-32 In addition to
recording activity from collective neuronal behavior,sin-
gle unit activity from temporal lobe neurons can be ana-
lyzed,thereby enabling the analysis of cognitive functions
at the single cell level.
33 Complementing these techniques,
functional imaging techniques offer high spatial resolution
but less precise temporal information about neuronal
activity.They also permit functional analysis of areas in
which electrode placement is clinically unnecessary,and
allow the analysis of structural and functional changes of
connectivity.The combination of these techniques is of
considerable interest,primarily because they are comple-
mentary with regard to spatial and temporal resolution.It
will therefore constitute a fundamental advance to acquire
combined (ie, simultaneous) intracranial electroen-
cephalogram (EEG)/single unit and functional magnetic
resonance imaging (fMRI) data during cognitive tasks.
While this will also contribute significantly to resolving the
current debate about the neuronal correlate of fMRI sig-
nals in humans,combining these technologies will enable
the investigation of the “brain at work” at an unprece-
dented degree of accuracy.A clinical demand also exists
for such combined recordings (ie,the detection of seizure
foci with spike-triggered fMRI).A simultaneous record-
ing of intracranial EEG/single units and fMRI is in prin-
ciple possible.Several companies are currently perform-
ing safety evaluations with pending applications for
approval of their intracranial electrodes for use within
fMRI scanners.
So far, analyses utilizing intracranial EEG recordings
have allowed important insights into the function of
mesial temporal lobe structures in the human,and have
allowed to directly study mechanisms underlying episodic
memory processes and their plasticity due to hippocam-
pal dysfunction in the human.They have also resulted in
an increased understanding of the perception and pro-
duction of language,and declarative memory functions
related to language.Interesting areas that can be studied
using such techniques are also those aimed at under-
standing how the human amygdala and hippocampus
process fear and emotional stimuli. Interaction with
researchers of other disciplines, such as economy and
social sciences,may permit the investigation of human
problem-solving mechanisms employing realistic para-
digms.A further interesting avenue is to conduct phar-
macological in-vivo studies, in which pharmacological
manipulations are performed in healthy subjects and
epilepsy patients (ie, N-methyl-D-aspartate [NMDA]
receptor antagonists),both during invasive depth elec-
trode recordings and fMRI experiments.
34 These
approaches have proven important to dissect out the con-
tribution of specific neurotransmitter systems to cogni-
tive functions.They also potentially provide an endophe-
notype that may predict drug efficacy or side effects.
Apart from functional imaging techniques,modern imag-
ing technologies provide an unprecendented look at struc-
tural changes in the human brain associated with epilepsy.
It has become increasingly clear that both functional (ie,
an hyperexcitable focus) or structural lesions can lead to
shifts in the local representation of function in the brain,
and to substantial changes in functional and structural con-
nectivity between brain areas. Using modern structural
and functional MRI techniques,such as diffusion tensor
imaging or dynamic causal modeling, allows analysis ofsuch changes in human subjects with excellent spatial res-
olution, with respect to the functions described above.
Such experiments will reveal the properties and time
course of structural and functional disease associated plas-
ticity,as well as which aspects of this plasticity can be influ-
enced (ie,by seizure suppression or epilepsy surgery).
Relationship of epilepsy to 
other neurological disorders
It is becoming increasingly clear that key molecules and
mechanisms responsible for the development of epilepsy
may also be pivotal in other neurological disorders.For
instance, evidence from animal studies suggests that
mechanisms of neuronal degeneration may be very sim-
ilar in models of epilepsy,trauma,ischemia,and perhaps
other chronic neurodegenerative disorders.Furthermore,
the conversion of glial cells to a reactive phenotype
occurs not only in epilepsy, but also in a wide range of
neurological disorders.There are numerous other exam-
ples for stereotypical,disease-associated plastic changes
in neurons in different neurological disorders.In addition
to these similarities,genetic studies also suggest shared
susceptibility factors. These shared molecular mecha-
nisms are thought to underlie the phenomenon of comor-
bidity (ie,an epidemiological association of epilepsy with
other disorders).Since it is likely that comorbidity results
from a shared genetic susceptibility,genetic approaches
are well-suited for identifying these common pathways.
An important further aspect is the availability of human
brain tissue in the context of an epilepsy surgical center
for cellular and molecular analyses, as well as in-vitro
physiology and pharmacology experiments.These human
brain materials represent a unique resource for the
assessment of specific pathophysiological hypotheses,
especially in combination with tissues from appropriate
animal models.Furthermore,frequent comorbid disor-
ders, such as depression, occur often enough within
epilepsy patient collectives to allow relevant numbers of
experiments using a combination of in-vivo physiology
and fMRI,on matched groups of epilepsy patients with
and without comorbid disorders.In contrast to electro-
physiological recordings, which can only be done on
epilepsy patients,fMRI studies can be performed on both
epilepsy patients,nonepileptic patients with comorbidity
(ie,depression or migraine),and control subjects.These
experiments will yield unique insights as to the relation-
ship between epilepsy,comorbid disorders,and cognitive
processes.They will also allow us to examine the effects
of drugs used in other CNS disorders on cognitive
processes with high resolution.
Conclusion
In summary, the study of the neurobiological basis of
epilepsy using approaches that integrate genetic,human
functional and behavioral studies,and work on animal
models, is important for developing novel therapeutic
strategies. It is also one of the few existing research
approaches that can be utilized to examine the function
of the human brain at high temporal,spatial,and cellular
resolution. ❏
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Investigación en epilepsia: una ventana
hacia la función y disfunción del cerebro
humano
La epilepsia es uno de los trastornos neurológicos
más comunes y tiene consecuencias conductuales,
sociales y ocupacionales devastadoras,  y se asocia
con daño cerebral acumulativo y déficit neurológi-
cos. La epilepsia incluye un gran número de sín-
dromes, que varían ampliamente en relación con la
etiología y los aspectos clínicos, pero que compar-
ten el sello clínico característico de la epilepsia: las
crisis espontáneas recurrentes. La investigación
orientada a la comprensión de las bases genéticas,
moleculares y celulares de la epilepsia ha integrado
varias aproximaciones y técnicas de investigación
que van desde la habilidad clínica, los análisis fun-
cionales de los sistemas y el nivel celular, tanto en
modelos de epilepsia en humanos como en roedo-
res, hasta la genética en ratones. Este conocimiento
entonces puede dar origen a nuevas opciones tera-
péuticas con mejor control de las convulsiones y/o
menores efectos secundarios. Además, el estudio de
la epilepsia frecuentemente ha dado luces acerca
de los mecanismos básicos que subyacen a la fun-
ción y disfunción del cerebro humano. 
Recherche sur l’épilepsie : une fenêtre sur le
fonctionnement et le dysfonctionnement du
cerveau humain
Les conséquences comportementales, sociales et
professionnelles de l’épilepsie, l’un des troubles
neurologiques les plus courants, sont dévastatrices.
L’épilepsie est associée à une accumulation d’alté-
rations cérébrales et de déficits neurologiques. Ses
syndromes sont nombreux et varient beaucoup
selon leur étiologie et leurs particularités cliniques,
mais partagent l’aspect clinique caractéristique de
l’épilepsie : les crises spontanées récidivantes. La
recherche s’est efforcée de comprendre les bases
génétiques, moléculaires et cellulaires de l’épilep-
sie en intégrant diverses approches et techniques
allant de l’expertise clinique, de l’analyse fonction-
nelle des systèmes à un niveau cellulaire, à la fois
chez les humains et dans des modèles murins d’épi-
lepsie, jusqu’à la génétique humaine et la géné-
tique murine. Grâce à cette connaissance, de nou-
veaux traitements pourraient être développés, les
crises mieux contrôlées et/ou les effets indésirables
plus restreints. L’étude de l’épilepsie a, en outre,
fréquemment permis d’éclairer les mécanismes de
base du fonctionnement et du dysfonctionnement
du cerveau humain.
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